首页 > 最新文献

The Open Virology Journal最新文献

英文 中文
Molecular Detection of Human Cytomegalovirus (HCMV) Among Infants with Congenital Anomalies in Khartoum State, Sudan 苏丹喀土穆州先天性异常婴儿中人类巨细胞病毒(HCMV)的分子检测
Pub Date : 2015-12-10 DOI: 10.2174/1874357901509010038
Maha G Ebrahim, Aisha S. Ali, Mohamed O. Mustafa, D. Musa, A. R. E. El Hussein, I. Elkhidir, K. Enan
Human Cytomegalovirus (HCMV) infection still represents the most common potentially serious viral complication in humans and is a major cause of congenital anomalies in infants. This study is aimed to detect HCMV in infants with congenital anomalies. Study subjects consisted of infants born with neural tube defect, hydrocephalus and microcephaly. Fifty serum specimens (20 males, 30 females) were collected from different hospitals in Khartoum State. The sera were investigated for cytomegalovirus specific immunoglobin M (IgM) antibodies using enzyme-linked immunosorbent assay (ELISA), and for Cytomegalovirus DNA using polymerase chain reaction (PCR). Out of the 50 sera tested, one patient’s (2%) sample showed HCMV IgM, but with no detectable DNA, other 4(8.2 %) sera were positive for HCMV DNA but with no detectable IgM. Various diagnostic techniques should be considered to evaluate HCMV disease and routine screening for HCMV should be introduced for pregnant women in this setting. It is vital to initiate further research work with many samples from different area to assess prevalence and characterize HCMV and evaluate its maternal health implications.
人类巨细胞病毒(HCMV)感染仍然是人类最常见的潜在严重病毒并发症,也是婴儿先天性异常的主要原因。本研究旨在检测先天性异常婴儿的HCMV。研究对象为新生儿神经管缺损、脑积水和小头畸形。从喀土穆州不同医院收集了50份血清标本(20名男性,30名女性)。采用酶联免疫吸附试验(ELISA)检测血清巨细胞病毒特异性免疫球蛋白M (IgM)抗体,采用聚合酶链反应(PCR)检测巨细胞病毒DNA。在50份检测的血清中,1名患者(2%)的样本显示HCMV IgM,但未检测到DNA,其他4名(8.2%)的样本显示HCMV DNA阳性,但未检测到IgM。应考虑各种诊断技术来评估HCMV疾病,并应在这种情况下对孕妇进行HCMV常规筛查。开展来自不同地区的大量样本的进一步研究工作,以评估HCMV的患病率和特征,并评估其对孕产妇健康的影响,这一点至关重要。
{"title":"Molecular Detection of Human Cytomegalovirus (HCMV) Among Infants with Congenital Anomalies in Khartoum State, Sudan","authors":"Maha G Ebrahim, Aisha S. Ali, Mohamed O. Mustafa, D. Musa, A. R. E. El Hussein, I. Elkhidir, K. Enan","doi":"10.2174/1874357901509010038","DOIUrl":"https://doi.org/10.2174/1874357901509010038","url":null,"abstract":"Human Cytomegalovirus (HCMV) infection still represents the most common potentially serious viral complication in humans and is a major cause of congenital anomalies in infants. This study is aimed to detect HCMV in infants with congenital anomalies. Study subjects consisted of infants born with neural tube defect, hydrocephalus and microcephaly. Fifty serum specimens (20 males, 30 females) were collected from different hospitals in Khartoum State. The sera were investigated for cytomegalovirus specific immunoglobin M (IgM) antibodies using enzyme-linked immunosorbent assay (ELISA), and for Cytomegalovirus DNA using polymerase chain reaction (PCR). Out of the 50 sera tested, one patient’s (2%) sample showed HCMV IgM, but with no detectable DNA, other 4(8.2 %) sera were positive for HCMV DNA but with no detectable IgM. Various diagnostic techniques should be considered to evaluate HCMV disease and routine screening for HCMV should be introduced for pregnant women in this setting. It is vital to initiate further research work with many samples from different area to assess prevalence and characterize HCMV and evaluate its maternal health implications.","PeriodicalId":23111,"journal":{"name":"The Open Virology Journal","volume":"467 1","pages":"38 - 41"},"PeriodicalIF":0.0,"publicationDate":"2015-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86717627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Detection of Human Polyomavirus DNA Using the Genome Profiling Method. 用基因组谱法检测人多瘤病毒DNA。
Pub Date : 2015-11-24 eCollection Date: 2015-01-01 DOI: 10.2174/1874357901509010029
Yuka Tanaka, Rieko Hirata, Kyohei Mashita, Stuart Mclean, Hiroshi Ikegaya

Background: In the field of forensic medicine, it is very difficult to know prior to autopsy what kind of virus has infected a body.

Objective: We assessed the potential of the genome profiling (GP) method, which was developed in the field of bioengineering, to identify viruses belonging to one species.

Method: Two species in the same family, JC and BK viruses, were used in this study. Using plasmid samples, we compared the findings of molecular phylogenetic analysis using conventional genome sequencing with the results of cluster analysis using the random PCR-based GP method and discussed whether the GP method can be used to determine viral species.

Results: It was possible to distinguish these two different viral species. In addition to this, in our trial we could also detect the JC virus from a clinical sample.

Conclusion: This method does not require special reagent sets for each viral species. Though our findings are still in the trial period, the GP method may be a simple, easy, and economical tool to detect viral species in the near future.

背景:在法医学领域,在尸检之前很难知道是哪种病毒感染了尸体。目的:研究生物工程领域发展起来的基因组分析(GP)方法在同一物种病毒鉴定中的应用潜力。方法:以同一科的JC病毒和BK病毒为研究对象。利用质粒样本,我们比较了传统基因组测序的分子系统发育分析结果与基于随机pcr的GP方法的聚类分析结果,并讨论了GP方法是否可以用于确定病毒种类。结果:可以区分这两种不同的病毒。除此之外,在我们的试验中,我们还可以从临床样本中检测到JC病毒。结论:该方法不需要对每种病毒都使用专用试剂。虽然我们的发现仍处于试验阶段,但在不久的将来,GP方法可能是一种简单、容易和经济的检测病毒物种的工具。
{"title":"Detection of Human Polyomavirus DNA Using the Genome Profiling Method.","authors":"Yuka Tanaka,&nbsp;Rieko Hirata,&nbsp;Kyohei Mashita,&nbsp;Stuart Mclean,&nbsp;Hiroshi Ikegaya","doi":"10.2174/1874357901509010029","DOIUrl":"https://doi.org/10.2174/1874357901509010029","url":null,"abstract":"<p><strong>Background: </strong>In the field of forensic medicine, it is very difficult to know prior to autopsy what kind of virus has infected a body.</p><p><strong>Objective: </strong>We assessed the potential of the genome profiling (GP) method, which was developed in the field of bioengineering, to identify viruses belonging to one species.</p><p><strong>Method: </strong>Two species in the same family, JC and BK viruses, were used in this study. Using plasmid samples, we compared the findings of molecular phylogenetic analysis using conventional genome sequencing with the results of cluster analysis using the random PCR-based GP method and discussed whether the GP method can be used to determine viral species.</p><p><strong>Results: </strong>It was possible to distinguish these two different viral species. In addition to this, in our trial we could also detect the JC virus from a clinical sample.</p><p><strong>Conclusion: </strong>This method does not require special reagent sets for each viral species. Though our findings are still in the trial period, the GP method may be a simple, easy, and economical tool to detect viral species in the near future.</p>","PeriodicalId":23111,"journal":{"name":"The Open Virology Journal","volume":"9 ","pages":"29-37"},"PeriodicalIF":0.0,"publicationDate":"2015-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396359/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34977813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis 爱泼斯坦-巴尔病毒:临床和流行病学回顾和肿瘤发生的遗传基础
Pub Date : 2015-11-03 DOI: 10.2174/1874357901509010007
A. Ali, M. Al-Shraim, A. Al-Hakami, I. Jones
Epstein-Barr virus (EBV) is classified as a member in the order herpesvirales, family herpesviridae, subfamily gammaherpesvirinae and the genus lymphocytovirus. The virus is an exclusively human pathogen and thus also termed as human herpesvirus 4 (HHV4). It was the first oncogenic virus recognized and has been incriminated in the causation of tumors of both lymphatic and epithelial nature. It was reported in some previous studies that 95% of the population worldwide are serologically positive to the virus. Clinically, EBV primary infection is almost silent, persisting as a life-long asymptomatic latent infection in B cells although it may be responsible for a transient clinical syndrome called infectious mononucleosis. Following reactivation of the virus from latency due to immunocompromised status, EBV was found to be associated with several tumors. EBV linked to oncogenesis as detected in lymphoid tumors such as Burkitt's lymphoma (BL), Hodgkin's disease (HD), post-transplant lymphoproliferative disorders (PTLD) and T-cell lymphomas (e.g. Peripheral T-cell lymphomas; PTCL and Anaplastic large cell lymphomas; ALCL). It is also linked to epithelial tumors such as nasopharyngeal carcinoma (NPC), gastric carcinomas and oral hairy leukoplakia (OHL). In vitro, EBV many studies have demonstrated its ability to transform B cells into lymphoblastoid cell lines (LCLs). Despite these malignancies showing different clinical and epidemiological patterns when studied, genetic studies have suggested that these EBV- associated transformations were characterized generally by low level of virus gene expression with only the latent virus proteins (LVPs) upregulated in both tumors and LCLs. In this review, we summarize some clinical and epidemiological features of EBV- associated tumors. We also discuss how EBV latent genes may lead to oncogenesis in the different clinical malignancies
eb病毒(EBV)属于疱疹病毒目、疱疹病毒科、伽玛疱疹病毒亚科和淋巴细胞病毒属。该病毒是一种专门的人类病原体,因此也被称为人类疱疹病毒4 (HHV4)。它是第一个被识别的致癌病毒,并被认为是淋巴和上皮性质肿瘤的病因。据以前的一些研究报告,全世界95%的人口在血清学上对该病毒呈阳性。在临床上,EBV原发性感染几乎是沉默的,尽管它可能导致一种称为传染性单核细胞增多症的短暂临床综合征,但它在B细胞中作为终身无症状潜伏感染持续存在。由于免疫功能低下状态导致病毒从潜伏期重新激活后,发现EBV与几种肿瘤有关。EBV与肿瘤发生有关,在淋巴样肿瘤如伯基特淋巴瘤(BL)、霍奇金病(HD)、移植后淋巴增生性疾病(PTLD)和t细胞淋巴瘤(如外周t细胞淋巴瘤;PTCL和间变性大细胞淋巴瘤;ALCL)。它还与鼻咽癌(NPC)、胃癌和口腔毛状白斑(OHL)等上皮性肿瘤有关。在体外,许多研究已经证明EBV能够将B细胞转化为淋巴母细胞样细胞系(LCLs)。尽管这些恶性肿瘤在研究中表现出不同的临床和流行病学模式,但遗传学研究表明,这些EBV相关转化的特征通常是低水平的病毒基因表达,只有潜伏病毒蛋白(LVPs)在肿瘤和lcl中上调。本文综述了EBV相关肿瘤的临床和流行病学特征。我们还讨论了EBV潜伏基因如何在不同的临床恶性肿瘤中导致肿瘤发生
{"title":"Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis","authors":"A. Ali, M. Al-Shraim, A. Al-Hakami, I. Jones","doi":"10.2174/1874357901509010007","DOIUrl":"https://doi.org/10.2174/1874357901509010007","url":null,"abstract":"Epstein-Barr virus (EBV) is classified as a member in the order herpesvirales, family herpesviridae, subfamily gammaherpesvirinae and the genus lymphocytovirus. The virus is an exclusively human pathogen and thus also termed as human herpesvirus 4 (HHV4). It was the first oncogenic virus recognized and has been incriminated in the causation of tumors of both lymphatic and epithelial nature. It was reported in some previous studies that 95% of the population worldwide are serologically positive to the virus. Clinically, EBV primary infection is almost silent, persisting as a life-long asymptomatic latent infection in B cells although it may be responsible for a transient clinical syndrome called infectious mononucleosis. Following reactivation of the virus from latency due to immunocompromised status, EBV was found to be associated with several tumors. EBV linked to oncogenesis as detected in lymphoid tumors such as Burkitt's lymphoma (BL), Hodgkin's disease (HD), post-transplant lymphoproliferative disorders (PTLD) and T-cell lymphomas (e.g. Peripheral T-cell lymphomas; PTCL and Anaplastic large cell lymphomas; ALCL). It is also linked to epithelial tumors such as nasopharyngeal carcinoma (NPC), gastric carcinomas and oral hairy leukoplakia (OHL). In vitro, EBV many studies have demonstrated its ability to transform B cells into lymphoblastoid cell lines (LCLs). Despite these malignancies showing different clinical and epidemiological patterns when studied, genetic studies have suggested that these EBV- associated transformations were characterized generally by low level of virus gene expression with only the latent virus proteins (LVPs) upregulated in both tumors and LCLs. In this review, we summarize some clinical and epidemiological features of EBV- associated tumors. We also discuss how EBV latent genes may lead to oncogenesis in the different clinical malignancies","PeriodicalId":23111,"journal":{"name":"The Open Virology Journal","volume":"10 1","pages":"7 - 28"},"PeriodicalIF":0.0,"publicationDate":"2015-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87688966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 40
Exploration of New Sites in Adenovirus Hexon for Foreign Peptides Insertion. 腺病毒六邻体外源肽插入新位点的探索。
Pub Date : 2015-05-29 eCollection Date: 2015-01-01 DOI: 10.2174/1874357901509010001
Satyender Hansra, Sujit Pujhari, Alexander N Zakhartchouk

Adenoviral vectors are now being explored as vaccine carriers to prevent infectious diseases in humans and animals. There are two strategies aimed at the expression of a vaccine antigen by adenoviral vectors. The first includes an insertion of the foreign gene expression cassette into the E1 region. The second strategy is antigen incorporation into the viral capsid proteins. To extend this methodology, we have searched for new sites at the human adenovirus serotype 5 major capsid protein hexon for a vaccine antigen insertion. To this end, we utilized sites in the hexon hypervariable region (HVR) 7, 8 and 9 to display a 15-mer peptide containing the main neutralizing epitope of porcine reproductive and respiratory syndrome virus. However, we could not rescue the viruses with the insertions of the peptide into HVR 8 and 9, consistent with the viruses being unable to tolerate insertions at these sites. In contrast, the virus with the insertion of the peptide in HVR 7 was viable - growing well in cell culture and the inserted peptide was exposed on the virion surface.

目前正在探索腺病毒载体作为预防人类和动物传染病的疫苗载体。有两种策略旨在通过腺病毒载体表达疫苗抗原。第一种方法包括将外源基因表达盒插入E1区。第二种策略是将抗原整合到病毒衣壳蛋白中。为了扩展这一方法,我们在人腺病毒血清型5主要衣壳蛋白六邻体上寻找新的位点,用于疫苗抗原插入。为此,我们利用六邻体高变区(HVR) 7、8和9的位点,展示了一个包含猪繁殖与呼吸综合征病毒主要中和表位的15-mer肽。然而,我们无法通过将肽插入hvr8和9来挽救病毒,这与病毒无法耐受这些位点的插入一致。与此相反,在hvr7中插入肽的病毒在细胞培养中生长良好,并且插入的肽暴露在病毒粒子表面。
{"title":"Exploration of New Sites in Adenovirus Hexon for Foreign Peptides Insertion.","authors":"Satyender Hansra,&nbsp;Sujit Pujhari,&nbsp;Alexander N Zakhartchouk","doi":"10.2174/1874357901509010001","DOIUrl":"https://doi.org/10.2174/1874357901509010001","url":null,"abstract":"<p><p>Adenoviral vectors are now being explored as vaccine carriers to prevent infectious diseases in humans and animals. There are two strategies aimed at the expression of a vaccine antigen by adenoviral vectors. The first includes an insertion of the foreign gene expression cassette into the E1 region. The second strategy is antigen incorporation into the viral capsid proteins. To extend this methodology, we have searched for new sites at the human adenovirus serotype 5 major capsid protein hexon for a vaccine antigen insertion. To this end, we utilized sites in the hexon hypervariable region (HVR) 7, 8 and 9 to display a 15-mer peptide containing the main neutralizing epitope of porcine reproductive and respiratory syndrome virus. However, we could not rescue the viruses with the insertions of the peptide into HVR 8 and 9, consistent with the viruses being unable to tolerate insertions at these sites. In contrast, the virus with the insertion of the peptide in HVR 7 was viable - growing well in cell culture and the inserted peptide was exposed on the virion surface. </p>","PeriodicalId":23111,"journal":{"name":"The Open Virology Journal","volume":"9 ","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2015-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/53/a3/TOVJ-9-1.PMC4460227.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33383777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Disease caused by rotavirus infection. 轮状病毒感染引起的疾病。
Pub Date : 2014-12-11 eCollection Date: 2014-01-01 DOI: 10.2174/1874357901408010014
Che-Liang Lin, Shou-Chien Chen, Shyun-Yeu Liu, Kow-Tong Chen

Although rotavirus vaccines are available, rotaviruses remain the major cause of childhood diarrheal disease worldwide. The Rotarix (GlaxoSmithKline Biologicals Rixensart, Belgium) and RotaTeq (Merck and Co., Inc. Whitehouse Station, New Jersey, USA) vaccines are effective for reducing the morbidity and mortality of rotavirus infection. This article aims to assess the epidemiology of rotaviral gastroenteritis and the efficacy and effectiveness of licensed rotavirus vaccines. This review concludes by presenting challenges in the field that require further exploration by and perspectives from basic and translational research in the future.

虽然轮状病毒疫苗是可用的,但轮状病毒仍然是世界范围内儿童腹泻病的主要原因。Rotarix(葛兰素史克生物制品公司Rixensart,比利时)和RotaTeq(默克公司)。Whitehouse Station, New Jersey, USA)疫苗对降低轮状病毒感染的发病率和死亡率是有效的。本文旨在评估轮状病毒胃肠炎的流行病学和已获批的轮状病毒疫苗的疗效和效果。本文最后提出了该领域面临的挑战,这些挑战需要未来基础研究和转化研究的进一步探索和展望。
{"title":"Disease caused by rotavirus infection.","authors":"Che-Liang Lin,&nbsp;Shou-Chien Chen,&nbsp;Shyun-Yeu Liu,&nbsp;Kow-Tong Chen","doi":"10.2174/1874357901408010014","DOIUrl":"https://doi.org/10.2174/1874357901408010014","url":null,"abstract":"<p><p>Although rotavirus vaccines are available, rotaviruses remain the major cause of childhood diarrheal disease worldwide. The Rotarix (GlaxoSmithKline Biologicals Rixensart, Belgium) and RotaTeq (Merck and Co., Inc. Whitehouse Station, New Jersey, USA) vaccines are effective for reducing the morbidity and mortality of rotavirus infection. This article aims to assess the epidemiology of rotaviral gastroenteritis and the efficacy and effectiveness of licensed rotavirus vaccines. This review concludes by presenting challenges in the field that require further exploration by and perspectives from basic and translational research in the future. </p>","PeriodicalId":23111,"journal":{"name":"The Open Virology Journal","volume":"8 ","pages":"14-9"},"PeriodicalIF":0.0,"publicationDate":"2014-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1874357901408010014","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32946978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Influenza A H1N1pdm 2009 Virus in Paraguay: Nucleotide Point Mutations in Hemagglutinin and Neuraminidase Genes are not Associated with Drug Resistance. 巴拉圭甲型H1N1pdm 2009病毒:血凝素和神经氨酸酶基因的核苷酸点突变与耐药性无关
Pub Date : 2014-09-29 eCollection Date: 2014-01-01 DOI: 10.2174/1874357901408010009
Emilio E Espínola, Alberto A Amarilla, Magaly Martínez, Víctor H Aquino, Graciela Russomando

Influenza virus is associated with upper respiratory tract infections. The fourth influenza pandemic was declared in 2009. The aim of this study was to determine the genetic variability of the 2009 H1N1 pandemic virus circulating in Paraguay. Nasal swabs were collected from 181 patients with flu symptoms managed at the Hospital of the Medical School in Asunción, Paraguay, between August and October 2009. Virus detection was carried out by real-time reverse transcription-polymerase chain reaction, followed by sequencing of the hemagglutinin and neuraminidase genes, and phylogenetic analysis. H1N1pdm09 was detected in 14.9% (27/181) of the suspected cases. Analysis of 13 samples showed that these viruses the clustered in a single genetic group. Neither the mutation related to exacerbation of disease (D239G in hemagglutinin) nor that related to antiviral resistance (H275Y in neuraminidase), both detected in neighboring countries, were found. This genetic analysis of H1N1pdm09 will help to understand the spread of the disease.

流感病毒与上呼吸道感染有关。2009年宣布了第四次流感大流行。本研究的目的是确定在巴拉圭流行的2009年H1N1大流行病毒的遗传变异。2009年8月至10月期间,在巴拉圭Asunción医学院医院对181名有流感症状的患者进行了鼻拭子采集。采用实时逆转录聚合酶链反应进行病毒检测,随后进行血凝素和神经氨酸酶基因测序,并进行系统发育分析。14.9%(27/181)疑似病例检出H1N1pdm09。对13个样本的分析表明,这些病毒聚集在一个遗传群体中。没有发现与疾病恶化相关的突变(血凝素中的D239G)和与抗病毒药物耐药性相关的突变(神经氨酸酶中的H275Y),这两种突变均在邻国检测到。对H1N1pdm09的基因分析将有助于了解这种疾病的传播。
{"title":"Influenza A H1N1pdm 2009 Virus in Paraguay: Nucleotide Point Mutations in Hemagglutinin and Neuraminidase Genes are not Associated with Drug Resistance.","authors":"Emilio E Espínola,&nbsp;Alberto A Amarilla,&nbsp;Magaly Martínez,&nbsp;Víctor H Aquino,&nbsp;Graciela Russomando","doi":"10.2174/1874357901408010009","DOIUrl":"https://doi.org/10.2174/1874357901408010009","url":null,"abstract":"<p><p>Influenza virus is associated with upper respiratory tract infections. The fourth influenza pandemic was declared in 2009. The aim of this study was to determine the genetic variability of the 2009 H1N1 pandemic virus circulating in Paraguay. Nasal swabs were collected from 181 patients with flu symptoms managed at the Hospital of the Medical School in Asunción, Paraguay, between August and October 2009. Virus detection was carried out by real-time reverse transcription-polymerase chain reaction, followed by sequencing of the hemagglutinin and neuraminidase genes, and phylogenetic analysis. H1N1pdm09 was detected in 14.9% (27/181) of the suspected cases. Analysis of 13 samples showed that these viruses the clustered in a single genetic group. Neither the mutation related to exacerbation of disease (D239G in hemagglutinin) nor that related to antiviral resistance (H275Y in neuraminidase), both detected in neighboring countries, were found. This genetic analysis of H1N1pdm09 will help to understand the spread of the disease. </p>","PeriodicalId":23111,"journal":{"name":"The Open Virology Journal","volume":"8 ","pages":"9-13"},"PeriodicalIF":0.0,"publicationDate":"2014-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/44/8f/TOVJ-8-9.PMC4200701.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32759306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Both Cyclophilin Inhibitors and Direct-Acting Antivirals Prevent PKR Activation in HCV-Infected Cells. 亲环蛋白抑制剂和直接作用抗病毒药物均可阻止hcv感染细胞中PKR的激活。
Pub Date : 2014-03-07 eCollection Date: 2014-01-01 DOI: 10.2174/1874357901408010001
Michael Bobardt, Udayan Chatterji, Precious Lim, Katarzyna Gawlik, Philippe Gallay

We and others demonstrated that the contact between NS5A and the host factor CypA is critical for HCV replication. CypI, by disrupting NS5A-CypA complexes, block HCV replication both in vitro and in patients. Since NS5A also binds to PKR, a central component of the IFN response, we investigated the possibility of a relationship between CypA, NS5A and PKR in the IFN response to HCV. HCV-infected cells treated with CypI, DAAs or IFN were analyzed for the expression and activation of various components of the innate response. We found that CypI (cyclosporine A, alisporivir, NIM811 and sanglifehrins), drastically prevented the activation/phosphorylation, but not the expression of IFN-induced PKR in HCV-infected cells. CypI had no effect on the expression or phosphorylation of other components of the innate response such as eiF2, NF-kB, IRF3, IRF9, STAT1 and STAT2, suggesting a specific effect on PKR. No significant activation of IFN-induced PKR was observed in the absence of HCV. Importantly, we found that several classes of DAAs such as NS3/4A protease, NS5B polymerase and NS5A inhibitors also prevented PKR activation. Furthermore, we found that PKR activation by the dsRNA mimic poly I:C cannot be prevented by CypI or DAAs. Our findings suggest that CypI do not have a unique effect on PKR activation, but rather the suppression of HCV replication by any anti-HCV inhibitor, abrogates PKR activation induced by IFN. Moreover, they suggest that the accumulation of dsRNA intermediates allows HCV to exploit the activation of PKR to counteract the IFN response.

我们和其他人证明NS5A和宿主因子CypA之间的接触对HCV复制至关重要。CypI通过破坏NS5A-CypA复合物,在体外和患者体内阻断HCV复制。由于NS5A也与PKR结合,PKR是IFN应答的核心组成部分,因此我们研究了CypA、NS5A和PKR在IFN对HCV应答中的关系。用CypI、DAAs或IFN处理hcv感染细胞,分析先天反应中各种成分的表达和激活。我们发现CypI (cyclosporine A, alisporivir, NIM811和sanglifehrins)可以显著阻止hcv感染细胞中ifn诱导的PKR的活化/磷酸化,但不能阻止其表达。CypI对先天应答的其他组分如eiF2、NF-kB、IRF3、IRF9、STAT1和STAT2的表达或磷酸化没有影响,这表明CypI对PKR有特异性影响。在没有HCV的情况下,没有观察到ifn诱导的PKR的显著激活。重要的是,我们发现几种daa如NS3/4A蛋白酶、NS5B聚合酶和NS5A抑制剂也能阻止PKR的激活。此外,我们发现PKR被dsRNA模拟poly I:C激活不能被CypI或DAAs阻止。我们的研究结果表明,CypI对PKR激活并没有独特的作用,而是通过任何抗HCV抑制剂抑制HCV复制,从而消除IFN诱导的PKR激活。此外,他们认为dsRNA中间体的积累允许HCV利用PKR的激活来抵消IFN的反应。
{"title":"Both Cyclophilin Inhibitors and Direct-Acting Antivirals Prevent PKR Activation in HCV-Infected Cells.","authors":"Michael Bobardt,&nbsp;Udayan Chatterji,&nbsp;Precious Lim,&nbsp;Katarzyna Gawlik,&nbsp;Philippe Gallay","doi":"10.2174/1874357901408010001","DOIUrl":"https://doi.org/10.2174/1874357901408010001","url":null,"abstract":"<p><p>We and others demonstrated that the contact between NS5A and the host factor CypA is critical for HCV replication. CypI, by disrupting NS5A-CypA complexes, block HCV replication both in vitro and in patients. Since NS5A also binds to PKR, a central component of the IFN response, we investigated the possibility of a relationship between CypA, NS5A and PKR in the IFN response to HCV. HCV-infected cells treated with CypI, DAAs or IFN were analyzed for the expression and activation of various components of the innate response. We found that CypI (cyclosporine A, alisporivir, NIM811 and sanglifehrins), drastically prevented the activation/phosphorylation, but not the expression of IFN-induced PKR in HCV-infected cells. CypI had no effect on the expression or phosphorylation of other components of the innate response such as eiF2, NF-kB, IRF3, IRF9, STAT1 and STAT2, suggesting a specific effect on PKR. No significant activation of IFN-induced PKR was observed in the absence of HCV. Importantly, we found that several classes of DAAs such as NS3/4A protease, NS5B polymerase and NS5A inhibitors also prevented PKR activation. Furthermore, we found that PKR activation by the dsRNA mimic poly I:C cannot be prevented by CypI or DAAs. Our findings suggest that CypI do not have a unique effect on PKR activation, but rather the suppression of HCV replication by any anti-HCV inhibitor, abrogates PKR activation induced by IFN. Moreover, they suggest that the accumulation of dsRNA intermediates allows HCV to exploit the activation of PKR to counteract the IFN response. </p>","PeriodicalId":23111,"journal":{"name":"The Open Virology Journal","volume":"8 ","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"2014-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9e/ba/TOVJ-8-1.PMC4009744.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32316736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines. 重组沙门氏菌载体HIV/AIDS疫苗。
Pub Date : 2013-12-30 eCollection Date: 2013-01-01 DOI: 10.2174/1874357901307010121
Nyasha Chin'ombe, Vurayai Ruhanya

HIV/AIDS is an important public health problem globally. An affordable, easy-to-deliver and protective HIV vaccine is therefore required to curb the pandemic from spreading further. Recombinant Salmonella bacteria can be harnessed to vector HIV antigens or DNA vaccines to the immune system for induction of specific protective immunity. These are capable of activating the innate, humoral and cellular immune responses at both mucosal and systemic compartments. Several studies have already demonstrated the utility of live recombinant Salmonella in delivering expressed foreign antigens as well as DNA vaccines to the host immune system. This review gives an overview of the studies in which recombinant Salmonella bacteria were used to vector HIV/AIDS antigens and DNA vaccines. Most of the recombinant Salmonella-based HIV/AIDS vaccines developed so far have only been tested in animals (mainly mice) and are yet to reach human trials.

艾滋病毒/艾滋病是一个重要的全球公共卫生问题。因此,需要一种负担得起、易于交付和具有保护作用的艾滋病毒疫苗,以遏制这一流行病的进一步蔓延。重组沙门氏菌可以利用载体HIV抗原或DNA疫苗对免疫系统诱导特异性保护性免疫。它们能够激活粘膜和系统隔室的先天、体液和细胞免疫反应。几项研究已经证明了活重组沙门氏菌在向宿主免疫系统递送表达的外源抗原和DNA疫苗方面的效用。本文综述了利用重组沙门氏菌载体HIV/AIDS抗原和DNA疫苗的研究进展。迄今为止开发的大多数基于沙门氏菌的重组艾滋病毒/艾滋病疫苗只在动物(主要是小鼠)身上进行了测试,尚未进入人体试验阶段。
{"title":"Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines.","authors":"Nyasha Chin'ombe,&nbsp;Vurayai Ruhanya","doi":"10.2174/1874357901307010121","DOIUrl":"https://doi.org/10.2174/1874357901307010121","url":null,"abstract":"<p><p>HIV/AIDS is an important public health problem globally. An affordable, easy-to-deliver and protective HIV vaccine is therefore required to curb the pandemic from spreading further. Recombinant Salmonella bacteria can be harnessed to vector HIV antigens or DNA vaccines to the immune system for induction of specific protective immunity. These are capable of activating the innate, humoral and cellular immune responses at both mucosal and systemic compartments. Several studies have already demonstrated the utility of live recombinant Salmonella in delivering expressed foreign antigens as well as DNA vaccines to the host immune system. This review gives an overview of the studies in which recombinant Salmonella bacteria were used to vector HIV/AIDS antigens and DNA vaccines. Most of the recombinant Salmonella-based HIV/AIDS vaccines developed so far have only been tested in animals (mainly mice) and are yet to reach human trials. </p>","PeriodicalId":23111,"journal":{"name":"The Open Virology Journal","volume":"7 ","pages":"121-6"},"PeriodicalIF":0.0,"publicationDate":"2013-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d9/84/TOVJ-7-121.PMC3905348.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32074982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Fulminant Hepatitis Due to Father-to-Newborn Transmission of Herpes Simplex Virus type 1. 单纯疱疹病毒1型由父亲传染给新生儿的暴发性肝炎。
Pub Date : 2013-10-31 eCollection Date: 2013-01-01 DOI: 10.2174/1874357901307010096
A Bal, C Zandotti, A Nougairede, L Ninove, B Roquelaure, R N Charrel

We describe a case of a severe neonatal infection by herpes simplex virus (HSV) type 1 acquired postnatally from his father. The delivery and the first days of life were normal. He developed liver failure and disseminated intravascular coagulation when he was 19 days old. He was treated with intravenous acyclovir and the outcome was favorable. This case underlines that prevention of post-natal transmission of HSV merits to be considered in educational pregnancy programs directed at mothers and fathers.

我们描述了一个病例严重的新生儿感染单纯疱疹病毒(HSV) 1型后天获得从他的父亲。分娩和生命的最初几天都很正常。他19天大时出现肝功能衰竭和弥漫性血管内凝血。他接受静脉注射阿昔洛韦治疗,结果良好。这个案例强调,预防HSV产后传播的优点,应考虑在教育怀孕方案针对母亲和父亲。
{"title":"Fulminant Hepatitis Due to Father-to-Newborn Transmission of Herpes Simplex Virus type 1.","authors":"A Bal,&nbsp;C Zandotti,&nbsp;A Nougairede,&nbsp;L Ninove,&nbsp;B Roquelaure,&nbsp;R N Charrel","doi":"10.2174/1874357901307010096","DOIUrl":"https://doi.org/10.2174/1874357901307010096","url":null,"abstract":"<p><p>We describe a case of a severe neonatal infection by herpes simplex virus (HSV) type 1 acquired postnatally from his father. The delivery and the first days of life were normal. He developed liver failure and disseminated intravascular coagulation when he was 19 days old. He was treated with intravenous acyclovir and the outcome was favorable. This case underlines that prevention of post-natal transmission of HSV merits to be considered in educational pregnancy programs directed at mothers and fathers. </p>","PeriodicalId":23111,"journal":{"name":"The Open Virology Journal","volume":"7 ","pages":"96-7"},"PeriodicalIF":0.0,"publicationDate":"2013-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a6/8c/TOVJ-7-96.PMC3821095.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31858896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Viral and Cellular Components of AAV2 Replication Compartments. AAV2复制区室的病毒和细胞成分。
Pub Date : 2013-10-31 eCollection Date: 2013-01-01 DOI: 10.2174/1874357901307010098
Rebecca Vogel, Michael Seyffert, Bruna de Andrade Pereira, Cornel Fraefel

Adeno-associated virus 2 (AAV2) is a helpervirus-dependent parvovirus with a bi-phasic life cycle comprising latency in absence and lytic replication in presence of a helpervirus, such as adenovirus (Ad) or herpes simplex virus type 1 (HSV-1). Helpervirus-supported AAV2 replication takes place in replication compartments (RCs) in the cell nucleus where virus DNA replication and transcription occur. RCs consist of a defined set of helper virus-, AAV2-, and cellular proteins. Here we compare the profile of cellular proteins recruited into AAV2 RCs or identified in Rep78-associated complexes when either Ad or HSV-1 is the helpervirus, and we discuss the potential roles of some of these proteins in AAV2 and helpervirus infection.

腺相关病毒2 (AAV2)是一种依赖辅助病毒的细小病毒,具有两期生命周期,包括无潜伏期和有辅助病毒(如腺病毒(Ad)或单纯疱疹病毒1型(HSV-1))存在时的裂解复制。辅助病毒支持的AAV2复制发生在细胞核的复制区室(RCs)中,在那里病毒DNA复制和转录发生。RCs由一组确定的辅助病毒-、AAV2-和细胞蛋白组成。在这里,我们比较了当Ad或HSV-1为辅助病毒时,募集到AAV2 RCs或在rep78相关复合体中鉴定的细胞蛋白的特征,并讨论了其中一些蛋白在AAV2和辅助病毒感染中的潜在作用。
{"title":"Viral and Cellular Components of AAV2 Replication Compartments.","authors":"Rebecca Vogel, Michael Seyffert, Bruna de Andrade Pereira, Cornel Fraefel","doi":"10.2174/1874357901307010098","DOIUrl":"10.2174/1874357901307010098","url":null,"abstract":"<p><p>Adeno-associated virus 2 (AAV2) is a helpervirus-dependent parvovirus with a bi-phasic life cycle comprising latency in absence and lytic replication in presence of a helpervirus, such as adenovirus (Ad) or herpes simplex virus type 1 (HSV-1). Helpervirus-supported AAV2 replication takes place in replication compartments (RCs) in the cell nucleus where virus DNA replication and transcription occur. RCs consist of a defined set of helper virus-, AAV2-, and cellular proteins. Here we compare the profile of cellular proteins recruited into AAV2 RCs or identified in Rep78-associated complexes when either Ad or HSV-1 is the helpervirus, and we discuss the potential roles of some of these proteins in AAV2 and helpervirus infection. </p>","PeriodicalId":23111,"journal":{"name":"The Open Virology Journal","volume":"7 ","pages":"98-120"},"PeriodicalIF":0.0,"publicationDate":"2013-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fd/54/TOVJ-7-98.PMC3822785.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31858315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
期刊
The Open Virology Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1